Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03266302Not ApplicableCompleted

Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis

Role: collaborator

NCT05299736Enrolling By Invitation

Human Impact Exposure Onboard High-Speed Boats

Role: collaborator

NCT05420142Phase 2Completed

Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products

Role: collaborator

NCT03356249Completed

Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis

Role: collaborator

All 4 trials loaded